NCI-H1703 In Vitro 8-isoprostane and iPF2α-VI Activity Assay (Oxidative Stress)
CAT#: ITS-0123-YF1216
Target Cell Organism: Human
Target Cell Alternative Name: H1703
Target Cell Name: NCI-H1703
Assay Type: Oxidative Stress Assays
Assay Overview
This assay is to provide NCI-H1703-based In Vitro 8-isoprostane and iPF2α-VI Activity Assay (Oxidative Stress) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H1703
Target Cell Organism
Human
Target Cell Background
NCI-H1703 was derived from a stage 1 lung squamous cell carcinoma of a 54-year-old Caucasian male smoker.
Target Cell Alternative Name
H1703
Related Diseases
Non Small Cell Lung Cancer
Research Area
Oncology
Assay Name
In Vitro 8-isoprostane and iPF2α-VI Activity Assay (Oxidative Stress)
Assay Description
Among isoprostanes, 8-isoprostane and iPF2α-VI have been considered as well-established markers for oxidative stress. A number of ELISA kits have been manufactured to determine 8-isoprostane and iPF2α-VI activity as an oxidative stress marker.
Assay Type
Oxidative Stress Assays
Assay Type Details
Disturbance between the production of reactive oxygen species (ROS), free radicals and antioxidant mechanisms is defined as the oxidative stress, or more precisely, it is an imbalance between the oxidant and antioxidant state in cells. This imbalance can cause harmful effects to cells and biomolecules, which ultimately causes adverse effects in the whole organism. Oxidative imbalance can target important proteinsand lipids in cells, which can increase the risk of developing a cancer. On the other hand, increased ROS production in cancer cells by certain cancer drugs can also arrest cancer cell cycle and cause senescence and apoptosis through oxidative stress.